As of 2025-07-06, the Intrinsic Value of Fujian Aonong Biological Technology Group Incorporation Ltd (603363.SS) is 5.22 CNY. This 603363.SS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 3.66 CNY, the upside of Fujian Aonong Biological Technology Group Incorporation Ltd is 42.60%.
The range of the Intrinsic Value is 3.73 - 8.29 CNY
Based on its market price of 3.66 CNY and our intrinsic valuation, Fujian Aonong Biological Technology Group Incorporation Ltd (603363.SS) is undervalued by 42.60%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 3.73 - 8.29 | 5.22 | 42.6% |
DCF (Growth 10y) | 7.52 - 16.07 | 10.32 | 182.1% |
DCF (EBITDA 5y) | 13.22 - 17.96 | 15.12 | 313.1% |
DCF (EBITDA 10y) | 18.79 - 28.18 | 22.60 | 517.4% |
Fair Value | 10.47 - 10.47 | 10.47 | 185.95% |
P/E | 0.78 - 9.19 | 4.46 | 21.9% |
EV/EBITDA | (6.38) - 5.68 | (1.01) | -127.6% |
EPV | (10.24) - (13.67) | (11.95) | -426.6% |
DDM - Stable | 2.52 - 6.71 | 4.62 | 26.1% |
DDM - Multi | 0.49 - 1.07 | 0.68 | -81.4% |
Market Cap (mil) | 9,526.83 |
Beta | 0.58 |
Outstanding shares (mil) | 2,602.96 |
Enterprise Value (mil) | 12,391.51 |
Market risk premium | 6.13% |
Cost of Equity | 10.62% |
Cost of Debt | 5.00% |
WACC | 8.92% |